Your session is about to expire
← Back to Search
Chemical Peel
Acid Peels for Melasma
N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour at baseline and week 16
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the safety and effectiveness of two types of chemical peels for treating melasma.
Who is the study for?
This trial is for adults with a noticeable patch of melasma on their face who are in good health and haven't had any chemical peels or used prescribed retinoids recently. Participants must not use other melasma treatments during the study and should not have bleeding disorders, abnormal wound healing, active facial diseases like severe acne, or be pregnant/lactating.
What is being tested?
The study is comparing the safety and effectiveness of two types of chemical peels for treating melasma: Salicylic Acid Peels versus Glycolic Acid Peels. It aims to determine which peel works better for this skin condition.
What are the potential side effects?
Potential side effects from both Salicylic and Glycolic acid peels may include redness, irritation, dryness, flaking or scaling of the skin. In some cases, there might be temporary darkening or lightening of the treated skin areas.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 hour at baseline and week 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour at baseline and week 16
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in best overall cosmetic appearance (right side or left side better)rated by a blinded dermatologist from baseline to week 16
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Glycolic Acid PeelsActive Control1 Intervention
Salicylic Acid and Glycolic Acid Chemical Peels are skin treatments used to correct uneven texture and color by removing dead cells from the skin's top layer.
Group II: Salicylic Acid PeelsActive Control1 Intervention
Salicylic Acid and Glycolic Acid Chemical Peels are skin treatments used to correct uneven texture and color by removing dead cells from the skin's top layer.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
958,573 Total Patients Enrolled
2 Trials studying Melasma
32 Patients Enrolled for Melasma
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,559 Total Patients Enrolled
2 Trials studying Melasma
32 Patients Enrolled for Melasma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a chemical peel within the last 3 months.You have taken a prescription retinoid medication within the last 3 months.You have a condition that causes problems with bleeding.You have had problems with healing wounds in the past.You have a skin condition, like severe acne, on your face that is not being treated or controlled.You have a history of scars that heal in an unusual way.You have been diagnosed with a mental illness.You have patches of melasma on both sides of your face, each at least 2 x 2 centimeters in size.You are generally healthy and in good overall condition.
Research Study Groups:
This trial has the following groups:- Group 1: Glycolic Acid Peels
- Group 2: Salicylic Acid Peels
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger